Dymax Unveils ‘2000-MW Series’ UV-Curable Adhesives for Medical Wearables, Featuring IBOA- and TPO-Free Formulation

August 30, 2026

Dymax USA

Overview

Dymax has launched its ‘2000-MW Series’ of light-curable, medical-grade adhesives specifically developed for wearable medical device assembly. Formulated without isobornyl acrylate (IBOA), a known skin irritant, and TPO, a substance of concern, the series is designed to be skin-friendly and safe for direct skin contact applications. Having passed ISO 10993-10/-23 (sensitization and irritation) and ISO 10993-5 (cytotoxicity), these adhesives ensure high reliability and robust bonding performance.

In Depth

Key Findings

Dymax has announced the release of its ‘2000-MW Series’ of light-curable, medical-grade adhesives, specifically formulated for the assembly of wearable medical devices. This new series is notable for its composition, which is free from isobornyl acrylate (IBOA), a common skin irritant, and TPO, a photoinitiator often flagged as a substance of concern. This design ensures the adhesives are safe for direct skin contact applications.

Technical & Product Details

Biocompatibility and Safety: The 2000-MW Series has successfully passed ISO 10993-10/-23 testing for sensitization and irritation, as well as ISO 10993-5 for cytotoxicity. These certifications confirm the skin-friendly properties, making them suitable for long-term wearable devices and other medical applications where patient safety is paramount.
High-Performance Adhesion: These adhesives provide strong bonds, flexibility, and durability, meeting the stringent performance requirements of medical devices. As light-curable materials, they offer rapid curing in seconds, significantly accelerating manufacturing processes and improving production efficiency.
Application Areas: The series is ideal for assembling a wide range of wearable medical devices, including continuous glucose monitors, heart rate sensors, drug delivery patches, and various diagnostic and therapeutic wearables. They demonstrate excellent adhesion to diverse substrates such as plastics, metals, and glass, commonly used in these devices.

Background & Context

The wearable medical device market is experiencing rapid growth, driven by advancements in telehealth and increasing interest in personal healthcare. These devices demand miniaturization, lightweighting, flexibility, and above all, high biocompatibility and reliability. Traditional adhesives have sometimes faced limitations in medical applications due to ingredients that could cause skin irritation or allergic reactions. The Dymax 2000-MW Series addresses these challenges, enabling safer and higher-performing product development.

Strategic Significance & Outlook

The introduction of Dymax’s 2000-MW Series provides medical device manufacturers with a crucial option for developing next-generation wearable technologies. The skin-friendly formulation combined with high reliability enhances patient comfort and safety, while also boosting product competitiveness in the market. This innovation is expected to accelerate advancements across broader medical fields, from diagnosis to therapy, further solidifying Dymax’s leadership in the medical adhesive market.

Source: https://dymax.cc/medical-wearables-device-assembly.html

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.